Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging

PurposeDiffuse midline glioma with histone H3 K27M mutation is a new entity described in the 2016 update of the World Health Organization Classification of Tumors of the Central Nervous System. The purpose of this study was to evaluate the clinical and imaging characteristics to predict the presence of H3 K27M mutation in spinal cord glioma using a machine learning–based classification model.MethodsA total of 41 spinal cord glioma patients consisting of 24 H3 K27M mutants and 17 wild types were enrolled in this retrospective study. A total of 17 clinical and radiological features were evaluated. The random forest (RF) model was trained with the clinical and radiological features to predict the presence of H3 K27M mutation. The diagnostic ability of the RF model was evaluated using receiver operating characteristic (ROC) analysis. Area under the ROC curves (AUC) was calculated.ResultsMR imaging features of spinal cord diffuse midline gliomas were heterogeneous. Hemorrhage was the only variable that was able to differentiate H3 K27M mutated tumors from wild-type tumors in univariate analysis (p = 0.033). RF classifier yielded 0.632 classification AUC (95% CI, 0.456–0.808), 63.4% accuracy, 45.8% sensitivity, and 88.2% specificity.ConclusionOur findings indicate that clinical and radiological features are associated with H3 K27M mutation status in spinal cord glioma.

[1]  Sabine Mueller,et al.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. , 2013, Genes & development.

[2]  David T. W. Jones,et al.  Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. , 2013, Cancer cell.

[3]  C. Hawkins,et al.  Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications , 2014, Acta Neuropathologica.

[4]  Kuniaki Saito,et al.  H3F3A K27M mutations in thalamic gliomas from young adult patients. , 2014, Neuro-oncology.

[5]  X. Qiu,et al.  Diffuse midline gliomas with histone H3‐K27M mutation: A rare case with PNET‐like appearance and neuropil‐like islands , 2018, Neuropathology : official journal of the Japanese Society of Neuropathology.

[6]  A. Shilatifard,et al.  Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling , 2014, Science.

[7]  M. Aboian,et al.  Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation , 2017, American Journal of Neuroradiology.

[8]  P. Knoepfler,et al.  Histone H3.3 mutations: a variant path to cancer. , 2013, Cancer cell.

[9]  A. Mukasa,et al.  PATH-28. CLINICAL AND GENETIC CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA IN THE SPINAL CORD , 2017 .

[10]  A. Friedman,et al.  Impact of Tumor Histology on Resectability and Neurological Outcome in Primary Intramedullary Spinal Cord Tumors: A Single-Center Experience With 102 Patients , 2011, Neurosurgery.

[11]  Arie Perry,et al.  Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations , 2016, Brain pathology.

[12]  T. Pietsch,et al.  High frequency of H3F3AK27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord , 2015, Acta Neuropathologica.

[13]  P. Varlet,et al.  Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes , 2015, Acta Neuropathologica.

[14]  Achim Zeileis,et al.  Bias in random forest variable importance measures: Illustrations, sources and a solution , 2007, BMC Bioinformatics.

[15]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[16]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[17]  David T. W. Jones,et al.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.

[18]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[19]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[20]  F. Ducray,et al.  Characteristics of H3 K27M-mutant gliomas in adults , 2017, Neuro-oncology.